Industry data shows emollients, protectives, have grown from Rs 1,390 crore MAT value in April 2022 to Rs 1,892 crore in April 2024. Likewise, sunscreens have grown from Rs 259 crore MAT value in April 2022 to Rs 416 crore in April 2024. MAT refers to Moving Annual Turnover (MAT).
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MLuYcWU
via IFTTT
-
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Ac...
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2024
(774)
-
▼
May
(75)
- Aurobindo Pharma signs pact with MSD to supply bio...
- Tata Capital Healthcare Fund invests $20 million i...
- Shedding light on weight loss struggles among diab...
- Anti-diabetic drugs lead growth in pharmaceuticals...
- India's pharma export sales to grow faster this year
- Pharma bosses told to submit affidavits on ethical...
- Emergence & Application of Generative AI in Insurance
- Delhi hospital fire: How unchecked private nursing...
- Fortis lines up Rs 1,300 cr capex to expand existi...
- Panel to examine if nutraceuticals can be produced...
- Chinese scientists develop cure for diabetes, insu...
- Dr Reddy's, Cipla, Sun Pharma & others to see FY25...
- Aster to invest Rs 250 crore in CMI Hospital, to u...
- Don’t pop that pill daily: Doctors red-flag proton...
- New plant of Sun Pharma inaugurated in Bangladesh
- Sun Pharma to pursue M&A, licensing to expand spec...
- Biocon inks licensing, supply pact with South Kore...
- Local pharma companies queue up for JB Chemicals &...
- Epidural during labour associated with 35% reduced...
- Max Healthcare to widen reach via acquisitions, sa...
- Emcure and its subsidiary Gennova settle legal dis...
- DCGI orders withdrawal of cancer drug Olaparib for...
- Strides Pharma unit gets USFDA nod for generic dru...
- Cipla gets USFDA nod to market Lanreotide injection
- Regulator asks state bodies to limit scope of key...
- Alvotech, Dr. Reddy's ink pact for commercialisati...
- KKR invests in Healthcare Revenue Solutions provid...
- JB Pharma expects India business to grow above mar...
- ICMR distances itself from BHU's Covaxin study
- KKR in talks to buy into healthcare BPO company In...
- Weight loss comparison: Stairs vs strolls – which ...
- 6 compelling reasons to feast on lychees this summer
- Dr Reddy's, Sun Pharma, Aurobindo recall products ...
- Wegovy should be treating more than just obesity
- India's drug regulator cracks down on antibiotic m...
- Serum Institute buys 20% stake in US-based Integri...
- Alembic Pharma plans to launch 25 drugs in US gene...
- AstraZeneca's COVID prevention drug meets primary ...
- Covaxin side effects: What are the symptoms report...
- Study on Covaxin reports adverse events in some pa...
- Adverse events seen in some participants who took ...
- Do you work night shifts? Here's what you need to ...
- Founder Sachdev to retain majority stake in Centre...
- Derma products market seeing strong growth
- Manipal Hospitals announces brand integration of A...
- Empowering healthcare innovations: Dr. Noura Khami...
- Kotak Alt to invest Rs 400 crore in medical device...
- Biocon inks supply, distribution pact with Medix f...
- Drug regulator forms panel to evaluate OTC candidates
- Good shot, bad shot: What you need to know about C...
- Heatwave ignites surge in chronic therapy demand
- Zydus Lifesciences gets USFDA approval for generic...
- Worrying vaccination gaps come to notice after pos...
- Covishield deaths could be more than estimates: Pa...
- Serum Institute of India says it stopped manufactu...
- USFDA issues Form 483 with 1 inspectional observat...
- India reverses old trend in medical consumables bu...
- 'Govt and industry should work together to reduce ...
- Paras Healthcare Private Limited performed Bhumi P...
- New all-in-one vaccine may prove effective against...
- Serum Institute of India challenges tax amendment ...
- Quadria Capital picks up stake in NephroPlus for $...
- What is new Covid variant FLiRT, is it dangerous, ...
- As high-tech era tips the scale in favour of newer...
- Every vaccine carries a risk. If benefits outweigh...
- The penicillin war: India's journey from self-suff...
- KKR to buy Healthium Medtech for Rs 7000 cr from Apax
- Regulator revokes state licensors' power to issue ...
- Dr Reddy's launches generic anti-bacterial drug in US
- Covishield maker AstraZeneca, SII, govt all respon...
- Quadria cap picks up minority stake in NephroPlus
- Bayer acquires remaining 25% stake in Bayer Zydus ...
- Maiva Pharma raises Rs 1,000 cr from Morgan Stanle...
- Maiva Pharma raises Rs 1000 crore from Morgan Stan...
- Took AstraZeneca's Covishield? Should I be worried...
-
▼
May
(75)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment